Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 1/2005

01-01-2005 | Article

Prevalence and risk factors of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in an Israeli long-term care facility

Authors: G. Mendelson, V. Hait, J. Ben-Israel, D. Gronich, E. Granot, R. Raz

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 1/2005

Login to get access

Abstract

The purpose of this study was to ascertain the prevalence of extended-spectrum beta-lactamases (ESBLs) among Escherichia coli and Klebsiella pneumoniae strains obtained from urine samples of residents of a long-term care facility and to determine the risk factors for acquisition of ESBL-producing strains. All urine samples collected from January 2003 to October 2003 that were positive for E. coli or K. pneumoniae were tested for the presence of ESBL. Records of patients with ESBL-positive (ESBL-P) samples were analyzed for clinical and demographic data. The records of a matched control group of patients whose urine samples were positive for E. coli or K. pneumoniae but were ESBL-negative (ESBL-N) were also analyzed. The overall rate of ESBLs among the E. coli and K. pneumoniae samples was 25.6%. Of 350 urine samples that grew E. coli, 77 (22%) were positive for ESBL; 34 of 84 (40.5%) samples that grew K. pneumoniae were ESBL-P. Male sex, treatment in the subacute care unit, recent antimicrobial treatment, pressure sores, (percutaneous endoscopic gastrostomy) PEG tube, anemia, hypoalbuminemia, permanent urinary catheter, and any recent invasive procedure were all associated with ESBL-P bacteria in the univariate analysis. The multivariate analysis revealed three independent risk factors for the presence of an ESBL-producing strain: anemia, permanent urinary catheter, and previous antibiotic use. Fluoroquinolones were most strongly associated with the development of ESBL-producing bacteria. The prevalence of ESBL-producing E. coli and K. pneumoniae in the long-term care facility investigated was unexpectedly high and corroborates the notion that long-term care facilities could be important reservoirs of resistant bacteria. Identification of the risk factors for ESBLs is the first step in formulating an effective strategy to curtail the spread of ESBL resistance in long-term care facilities.
Literature
1.
go back to reference Bush K (1996) Is it important to identify extended spectrum beta-lactamase producing isolates? Eur J Clin Microb Infect Dis 15:361–364 Bush K (1996) Is it important to identify extended spectrum beta-lactamase producing isolates? Eur J Clin Microb Infect Dis 15:361–364
2.
go back to reference Bradford PA (2001) Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology and detection of this important resistance threat. Clin Microb Rev 14:933–951 Bradford PA (2001) Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology and detection of this important resistance threat. Clin Microb Rev 14:933–951
3.
go back to reference Shah PW, Stille W (1983) Escherichia coli and Klebsiella pneumoniae strains more susceptible to cefoxitin than to third-generation cephalosporins. J Antimicrob Chemother 11:597–598PubMed Shah PW, Stille W (1983) Escherichia coli and Klebsiella pneumoniae strains more susceptible to cefoxitin than to third-generation cephalosporins. J Antimicrob Chemother 11:597–598PubMed
4.
go back to reference Jarlier V, Nicolas MH, Fournier G, Philippon A (1988) Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility pattern. Rev Infect Dis 10:867–878PubMed Jarlier V, Nicolas MH, Fournier G, Philippon A (1988) Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility pattern. Rev Infect Dis 10:867–878PubMed
5.
go back to reference Gordon KA, Jones RN, and the SENTRYParticipant Groups (Europe, Latin America, North America) (2003) Susceptibility patterns of orally administered antimicrobials among urinary tract infection pathogens from hospitalized patients in North America: comparison report to Europe and Latin America. Results from the SENTRY Antimicrobial Surveillance Program (200). Diagn Microbiol Infect Dis 45:295–301PubMed Gordon KA, Jones RN, and the SENTRYParticipant Groups (Europe, Latin America, North America) (2003) Susceptibility patterns of orally administered antimicrobials among urinary tract infection pathogens from hospitalized patients in North America: comparison report to Europe and Latin America. Results from the SENTRY Antimicrobial Surveillance Program (200). Diagn Microbiol Infect Dis 45:295–301PubMed
6.
go back to reference Winokur PL, Canton R, Casellas JM, Legakis N (2001) Variations in the prevalence of strains expressing an extended-spectrum β-lactamase phenotype and characterization of isolates from Europe, the Americas and the Western Pacific Region 32(Suppl 2):S94–S103 Winokur PL, Canton R, Casellas JM, Legakis N (2001) Variations in the prevalence of strains expressing an extended-spectrum β-lactamase phenotype and characterization of isolates from Europe, the Americas and the Western Pacific Region 32(Suppl 2):S94–S103
7.
go back to reference Larson LL, Ramphal R (2002) Extended-spectrum beta-lactamases. Semin Respir Infect 17:189–194PubMed Larson LL, Ramphal R (2002) Extended-spectrum beta-lactamases. Semin Respir Infect 17:189–194PubMed
8.
go back to reference Clarridge JE, Johnson JR, Pezzlo MT (1998) Laboratory diagnosis of urinary tract infections. In: Weissfeld AS (ed) Cumitech 2B. American Society for Microbiology, Washington, DC Clarridge JE, Johnson JR, Pezzlo MT (1998) Laboratory diagnosis of urinary tract infections. In: Weissfeld AS (ed) Cumitech 2B. American Society for Microbiology, Washington, DC
10.
go back to reference Paterson DL, Ko WC, Von Gottberg A et al (2004) International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum β-lactamase production in nosocomial infections. Ann Intern Med 140:26–32PubMed Paterson DL, Ko WC, Von Gottberg A et al (2004) International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum β-lactamase production in nosocomial infections. Ann Intern Med 140:26–32PubMed
11.
go back to reference Einhorn AE, Neuhauser MM, Bearden DT, Quinn JP, Pendland SL (2002) Extended-spectrum beta-lactamases: frequency, risk factors and outcomes. Pharmacotherapy 22:14–20 Einhorn AE, Neuhauser MM, Bearden DT, Quinn JP, Pendland SL (2002) Extended-spectrum beta-lactamases: frequency, risk factors and outcomes. Pharmacotherapy 22:14–20
12.
go back to reference Mylette JM, Goodnough S, Tayara A (2001) Antibiotic-resistant organisms among long-term care facility residents on admission to an inpatient geriatrics unit: retrospective and prospective surveillance. Am J Infect Control 29:139–144PubMed Mylette JM, Goodnough S, Tayara A (2001) Antibiotic-resistant organisms among long-term care facility residents on admission to an inpatient geriatrics unit: retrospective and prospective surveillance. Am J Infect Control 29:139–144PubMed
13.
go back to reference Smith PW, Seip CW, Schaefer SC, Bell-Dixon C (2000) Microbiologic survey of long-term care facilities. Am J Infect Control 28:8–13PubMed Smith PW, Seip CW, Schaefer SC, Bell-Dixon C (2000) Microbiologic survey of long-term care facilities. Am J Infect Control 28:8–13PubMed
14.
go back to reference Weiner J, Quinn JP, Bradfore PA, Goering RV, Nathum C, Bush K, Weinstein RA (1999) Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 281:517–523CrossRefPubMed Weiner J, Quinn JP, Bradfore PA, Goering RV, Nathum C, Bush K, Weinstein RA (1999) Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 281:517–523CrossRefPubMed
15.
go back to reference Shah AA, Hasan F, Ahmed S, Hameed A (2002) Extended-spectrum beta-lactamases in Enterobacteriaceae: related to age and gender. New Microbiol 25:363–366PubMed Shah AA, Hasan F, Ahmed S, Hameed A (2002) Extended-spectrum beta-lactamases in Enterobacteriaceae: related to age and gender. New Microbiol 25:363–366PubMed
16.
go back to reference Safdar N, Maki DG (2002) The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, Gram-negative bacilli, Clostridium difficile and Candida. Ann Intern Med 136:834–844PubMed Safdar N, Maki DG (2002) The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, Gram-negative bacilli, Clostridium difficile and Candida. Ann Intern Med 136:834–844PubMed
17.
go back to reference Bauernfeld A, Abele-Horn M, Emmerling P, Jungwirth B (1994) Multiclonal emergence of ciprofloxacin-resistant clinical isolates of Escherichia coli and Klebsiella pneumoniae. J Antimicrob Chemother 34:1074–1076PubMed Bauernfeld A, Abele-Horn M, Emmerling P, Jungwirth B (1994) Multiclonal emergence of ciprofloxacin-resistant clinical isolates of Escherichia coli and Klebsiella pneumoniae. J Antimicrob Chemother 34:1074–1076PubMed
18.
go back to reference Richard P, Delangle MH, Raffi F, Espaze E, Richet H (2001) Impact of fluoroquinolone administration on the emergence of fluoroquinolone-resistant Gram-negative bacilli from gastrointestinal flora. Clin Infect Dis 32:162–166PubMed Richard P, Delangle MH, Raffi F, Espaze E, Richet H (2001) Impact of fluoroquinolone administration on the emergence of fluoroquinolone-resistant Gram-negative bacilli from gastrointestinal flora. Clin Infect Dis 32:162–166PubMed
19.
go back to reference Jacoby GA (1998) Editorial response: epidemiology of extended-spectrum β-lactamases. Clin Infect Dis 27:81–83PubMed Jacoby GA (1998) Editorial response: epidemiology of extended-spectrum β-lactamases. Clin Infect Dis 27:81–83PubMed
20.
go back to reference Bradley SF (1997) Methicillin-resistant Staphylococcus aureus in long-term care facilities: epidemiology, prevention and management. Drugs Aging 10:185–198PubMed Bradley SF (1997) Methicillin-resistant Staphylococcus aureus in long-term care facilities: epidemiology, prevention and management. Drugs Aging 10:185–198PubMed
21.
go back to reference Silverblatt FJ, Tibert C, Mikolich D (2000) Preventing the spread of vancomycin-resistant enterococci in a long-term care facility. J Am Geriatr Soc 48:1211–1215PubMed Silverblatt FJ, Tibert C, Mikolich D (2000) Preventing the spread of vancomycin-resistant enterococci in a long-term care facility. J Am Geriatr Soc 48:1211–1215PubMed
22.
go back to reference Chenoweth CE, Bradley SF, Terpenning MS, Zarins LT, Ramsey MA, Schaberg DR et al (1994) Colonization and transmission of high-level gentamicin-resistant enterococci in a long-term care facility. Infect Control Hosp Epidemiol 15:703–709PubMed Chenoweth CE, Bradley SF, Terpenning MS, Zarins LT, Ramsey MA, Schaberg DR et al (1994) Colonization and transmission of high-level gentamicin-resistant enterococci in a long-term care facility. Infect Control Hosp Epidemiol 15:703–709PubMed
23.
go back to reference Mendelson G, Yearmack Y, Granot E, Ben-Israel J, Colodner R, Raz R (2003) S. aureus carrier state among elderly residents of a long-term care facility in northern Israel. J Am Med Directors Assoc 4:125–127CrossRef Mendelson G, Yearmack Y, Granot E, Ben-Israel J, Colodner R, Raz R (2003) S. aureus carrier state among elderly residents of a long-term care facility in northern Israel. J Am Med Directors Assoc 4:125–127CrossRef
Metadata
Title
Prevalence and risk factors of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in an Israeli long-term care facility
Authors
G. Mendelson
V. Hait
J. Ben-Israel
D. Gronich
E. Granot
R. Raz
Publication date
01-01-2005
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 1/2005
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-004-1264-8

Other articles of this Issue 1/2005

European Journal of Clinical Microbiology & Infectious Diseases 1/2005 Go to the issue